These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19578232)

  • 21. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
    Remy AJ; Wenger H; Bouchkira H
    Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
    [No Abstract]   [Full Text] [Related]  

  • 24. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
    Waizmann M; Ackermann G
    J Subst Abuse Treat; 2010 Jun; 38(4):338-45. PubMed ID: 20362408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.
    Souliotis K; Agapidaki E; Papageorgiou M; Voudouri N; Contiades X
    Int J Equity Health; 2017 Jun; 16(1):101. PubMed ID: 28615023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
    Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
    Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
    Jerkeman A; Norkrans G; Lidman C; Westin J; Lagging M; Frimand J; Simonsberg C; Kakko J; Widell A; Björkman P
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):523-31. PubMed ID: 24637496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up studies of treatment for hepatitis C virus infection among injection drug users.
    Dalgard O
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S336-8. PubMed ID: 15768344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
    McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
    Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is killing people with hepatitis C virus infection?
    Grebely J; Dore GJ
    Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Lewis H; Kunkel J; Axten D; Dalton J; Gardner H; Tippett A; Wynne S; Wilkinson M; Foster GR
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1258-63. PubMed ID: 27487966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.